Regulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer’s drug success
admin Next stop regulatory approval. That was the view of analysts at Mizuho Securities, who late…
Read MoreCorporate Actions
Tyson Foods shuffles leadership team, names new CFO
Tyson Foods Inc. TSN, -0.57% on Tuesday shuffled its leadership team. The meat processor said…
Read MoreGoldman Sachs readies $300 million in M&A deals with fresh pool of private capital
Goldman Sachs Group Inc. said Tuesday it raised $9.7 billion in commitments for its private-equity…
Read MoreCrypto exchange FTX wins bid for Voyager’s assets
FTX US has won the bid for Voyager Digital’s assets for about $1.4 billion, more…
Read MoreHarley spinoff LiveWire’s stock surges in NYSE debut
The new shares of LiveWire Group Inc. charged higher Tuesday as investors prepped for the…
Read MoreHarley spinoff LiveWire’s stock set to surge in NYSE debut
The new shares of LiveWire Group Inc. charged higher in premarket trading Tuesday, as investors…
Read MoreCompanies are trying to blame weak earnings on the strong U.S. dollar, but that’s a lame excuse
Many corporations would have you believe that the strong U.S. dollar is why earnings targets…
Read MoreDepositions for Elon Musk, Twitter CEO Parag Agrawal delayed as trial looms
Twitter Inc. and Elon Musk continue to jockey for preliminary legal advantage ahead of a…
Read MoreBowflex maker Nautilus seeks ‘strategic alternatives,’ including possible sale
Nautilus Inc. stock rallied as much as 12% in the extended session Monday after the…
Read More
22 dividend stocks screened for quality and safety
Now that the S&P 500 has hit a new closing low for 2022, it is…
Read More